Indaptus Therapeutics Reports Positive Decoy20 Phase 1 Trial ResultsBy topmanagerMarch 4, 20240 Indaptus Therapeutics saw a significant increase in shares, rising by 26% to $2.63 in premarket trading following the announcement of…
Moderna Unveils Promising Results from Cancer Treatment TrialBy topmanagerDecember 14, 20230 Moderna, in partnership with Merck, has released updated data from an ongoing early-stage trial of their innovative cancer treatment. The…